IMRX · Immuneering Corp
$5.21
+0.15 (+2.96%)
At close · Aug 17
Market Cap
$327.37M
Shares
64.70M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-08-13 | — | $98,749,993 | $98,749,993 as of 2026-03-31 | — | 10-Q , filed 2026-05-15 |
Key facts
CIK
1790340
CUSIP
45254E107
13F (30d)
107 filings
106 filers
Visit website
Investor relations